These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1395090)

  • 1. Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?
    Spronk PE; ter Borg EJ; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1992 Oct; 90(1):106-10. PubMed ID: 1395090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus.
    ter Borg EJ; Horst G; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1990 Oct; 82(1):21-6. PubMed ID: 2208793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.
    Thanadetsuntorn C; Ngamjanyaporn P; Setthaudom C; Hodge K; Saengpiya N; Pisitkun P
    Sci Rep; 2018 Feb; 8(1):2620. PubMed ID: 29422675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
    Tripathy R; Panda AK; Das BK
    Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of serum C-reactive protein in systemic lupus erythematosus.
    Williams RC; Harmon ME; Burlingame R; Du Clos TW
    J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus.
    Wang H; Cao J; Lai X
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28036035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus.
    Sturfelt G; Roux-Lombard P; Wollheim FA; Dayer JM
    Br J Rheumatol; 1997 Dec; 36(12):1283-9. PubMed ID: 9448589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus.
    Miyawaki S; Nishiyama S; Aita T; Yoshinaga Y
    Mod Rheumatol; 2013 Jul; 23(4):659-66. PubMed ID: 23011357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study.
    ter Borg EJ; Horst G; Limburg PC; van Rijswijk MH; Kallenberg CG
    J Rheumatol; 1990 Dec; 17(12):1642-8. PubMed ID: 2084238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical disease activity and titers of anti-dsDNA antibodies measured by an automated immunofluorescence assay in patients with systemic lupus erythematosus.
    López-Hoyos M; Cabeza R; Martínez-Taboada VM; Crespo J; SanSegundo D; Blanco R; López-Escribano H; Peña M; Rodríguez-Valverde V
    Lupus; 2005; 14(7):505-9. PubMed ID: 16130504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
    Garabet L; Gilboe IM; Mowinckel MC; Jacobsen AF; Mollnes TE; Sandset PM; Jacobsen EM
    Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hematological abnormalities in systemic lupus erythematosus and clinical significance thereof: comparative analysis of 236 cases].
    Chen JL; Huang XM; Zeng XJ; Wang Y; Zhou MX; Ma YH; Li RS; Shen T
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1330-3. PubMed ID: 17727778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus.
    Park YB; Lee SK; Kim DS; Lee J; Lee CH; Song CH
    Clin Exp Rheumatol; 1998; 16(3):283-8. PubMed ID: 9631750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemia in males with systemic lupus erythematosus.
    Mok CC; Lau CS; Lee KW; Wong RW
    J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.
    Zhou H; Li B; Li J; Wu T; Jin X; Yuan R; Shi P; Zhou Y; Li L; Yu F
    Mediators Inflamm; 2019; 2019():8450947. PubMed ID: 31007604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CII antibody as a novel indicator to assess disease activity in systemic lupus erythematosus.
    He C; Mao T; Feng Y; Song T; Qin C; Yan R; Feng P
    Lupus; 2015 Nov; 24(13):1370-6. PubMed ID: 26048288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients?
    Umare V; Nadkarni A; Nadkar M; Rajadhyksha A; Khadilkar P; Ghosh K; Pradhan VD
    J Postgrad Med; 2017; 63(2):92-95. PubMed ID: 27531690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sub-setting systemic lupus erythematosus by combined molecular phenotypes defines divergent populations in two phase III randomized trials.
    Petri M; Watts SD; Higgs RE; Linnik MD
    Rheumatology (Oxford); 2021 Nov; 60(11):5390-5396. PubMed ID: 33580248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.